Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Miller

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorinR M Goldberg, S H Kaufmann, P Atherton, et al.
Journal of Applied Microbiology|August 10, 2013
D-cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategiesT O Omotade, J D Heffron, C P Klimko, et al.
The American Journal of Pathology|August 1, 1995
Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allograftsJ M Gulizia, R Kandolf, T J Kendall, et al.
Archives of Oral Biology|February 1, 1996
Absence of detrimental effects of fluoride exposure in diabetic ratsA J Dunipace, C A Wilson, M E Wilson, et al.
Cancer Research|March 15, 1987
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxinL E Spitler, M del Rio, A Khentigan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancerR F DeVore, D H Johnson, J Crawford, et al.
The American Journal of Pathology|August 1, 1995
Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathyB M McManus, K J Horley, J E Wilson, et al.
Research in Nursing & Health|February 1, 1995
The PREP system of nursing interventions: a pilot test with families caring for older members. Preparedness (PR), enrichment (E) and predictability (P)P G Archbold, B J Stewart, L L Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignanciesJ W Smith, W J Urba, B D Curti, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|March 1, 1996
Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancerB D Curti, W J Urba, D L Longo, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorinR M Goldberg, S H Kaufmann, P Atherton, et al.
Journal of Applied Microbiology|August 10, 2013
D-cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategiesT O Omotade, J D Heffron, C P Klimko, et al.
The American Journal of Pathology|August 1, 1995
Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allograftsJ M Gulizia, R Kandolf, T J Kendall, et al.
Archives of Oral Biology|February 1, 1996
Absence of detrimental effects of fluoride exposure in diabetic ratsA J Dunipace, C A Wilson, M E Wilson, et al.
Cancer Research|March 15, 1987
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxinL E Spitler, M del Rio, A Khentigan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancerR F DeVore, D H Johnson, J Crawford, et al.
The American Journal of Pathology|August 1, 1995
Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathyB M McManus, K J Horley, J E Wilson, et al.
Research in Nursing & Health|February 1, 1995
The PREP system of nursing interventions: a pilot test with families caring for older members. Preparedness (PR), enrichment (E) and predictability (P)P G Archbold, B J Stewart, L L Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignanciesJ W Smith, W J Urba, B D Curti, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|March 1, 1996
Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancerB D Curti, W J Urba, D L Longo, et al.
Pageof 18